LUNDBECK INSTITUTE
"LUNDBECK INSTITUTE" is a figurative mark owned by H. Lundbeck A/S, filed at the USPTO on May 16, 2024. It is registered and covers classes 5, 9, 16, 38, 41 and 42.
- Status
- Registered
- Since June 3, 2025
- Filed
- May 16, 2024
- Registered
- June 3, 2025
- Priority date
- May 8, 2024
- Claimed from Denmark
- Application no.
- 98553575
- Registration no.
- 7814488
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 6 classes
Who owns LUNDBECK INSTITUTE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
H. Lundbeck A/S
Valby, Denmark
Representative
Maren C. Perry
King & Spalding LLP
What the mark covers
The products and services LUNDBECK INSTITUTE is filed for, grouped by Nice class.
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances, for the treatment of disorders and diseases acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood swings, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinsons disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and suffering, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourettes syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, drowsiness, nausea, migraine, pain, alcoholism and addiction; diagnostic preparations, substances, reagents and agents for medical purposes
Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; downloadable and recorded computer software for creating searchable databases of medical and pharmaceutical information, education, namely, educational software featuring instruction in medicine and sales activities, namely, software for others for use in sales management; downloadable and recorded computer software for analyzing medical and pharmaceutical information and disease awareness; software, namely, downloadable and recorded application software for mobile devices in the nature of mobile phones, namely, software for analyzing medical and pharmaceutical information; apparatus and instruments, namely, downloadable computer software for analyzing medical and pharmaceutical information in the field of research and development, science, clinical studies, medical clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; electronic downloadable publications, namely, magazines, journals, teaching and educational materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention; downloadable and recorded application software for mobile devices in the nature of mobile phones, namely, software for the assessment of cognitive functions; downloadable computer software for the assessment of cognitive functions; downloadable and recorded computer software for use in diagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, migraine, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine
Printed publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, records in the nature of informational sheets, educational and training materials for research and development, science, clinical studies, tests and trials, diagnostics, medicine, drugs, disorders, diseases, treatment and prevention
Arranging and conducting an online forum in the field of pharmaceuticals, disease awareness and treatments; providing online chat rooms and electronic bulletin boards for transmission of messages among computer users in the field of pharmaceuticals, disease awareness and treatments
Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the nature of conferences, courses, seminars and workshops in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational training services in the nature of conferences, courses, seminars and workshops in the fields of pharmaceutical research and development, medical clinical studies, pharmaceutical tests and trials and diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services electronically in the nature of online and non-downloadable, on-line, via cable and Internet and other electronic media, namely, podcasts, audio and visual media; arranging and conducting expert forums, namely, on-line training programs in the field of pharmaceuticals; providing online, non- downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, disease awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non- downloadable screening tools
Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic research and tests, namely, providing diagnostic services for others for scientific research purposes in the field of pharmaceutical research
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of non-final action e-mailed
5 earlier steps on the official record.
About LUNDBECK INSTITUTE
Who owns the trademark "LUNDBECK INSTITUTE"?
The USPTO trademark "LUNDBECK INSTITUTE" (application 98553575) is owned by H. Lundbeck A/S.
What is the status of "LUNDBECK INSTITUTE"?
Its status at the USPTO is: registered.
When was "LUNDBECK INSTITUTE" registered?
It was registered on June 3, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull LUNDBECK INSTITUTE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2ce7-93c8-71c8-a756-0a42efbe0501
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2ce7-93c8-71c8-a756-0a42efbe0501",
"object": "trademark",
"mark_text": "LUNDBECK INSTITUTE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98553575",
"filing_date": "2024-05-16",
"nice_classes": [
5,
9,
16,
38,
41,
42
],
"owners": [
{
"name": "H. Lundbeck A/S",
"entity_id": "ent_019eb6fd-c6b8-7323-bcf8-455bb92dfb3d"
}
]
}